For US Healthcare Professionals Only
For questions about coronavirus/COVID-19 and using NIOX VERO®, please visit the NIOX VERO Coronavirus/COVID-19 FAQ.
NIOX has been the preferred FeNO device used in global research trials for almost ten years by pharmaceutical companies, clinical research organizations, and government and academic groups. Monitoring FeNO has proved to be a valuable biomarker and is continually included in clinical trial protocols.1
Circassia can provide the following services for your research needs:
References: 1. Data on file. Circassia Ltd.